Rupam Manna/LinkedIn
Jul 19, 2026, 16:59
Rupam Manna: Not All Portal Vein Involvement in HCC Is the Same
Rupam Manna, Postdoctoral Student – DrNB Medical Oncology at National Board of Examinations, shared a post on X:
“Not all portal vein involvement in HCC is the same.
The Vp classification helps define the extent of portal vein tumor thrombosis (PVTT) – one of the most important factors influencing prognosis and treatment strategy in hepatocellular carcinoma.
- Vp0–Vp2: Early vascular involvement where selected patients may still benefit from surgery or locoregional therapies.
- Vp3–Vp4: Major portal vein invasion, usually requiring systemic therapy, with Y-90 radioembolization (TARE) emerging as an important option in carefully selected patients.
Understanding the anatomy of portal vein invasion is key to making the right therapeutic decision.
Save this infographic for a quick review and share it with colleagues interested in liver cancer.”

Stay updated with Hemostasis Today.
-
Jul 21, 2026, 00:55Anita Brikman on PPTA’s First-Half 2026 Achievements
-
Jul 21, 2026, 00:50Caitlin Raymond: Can Therapeutic Plasma Exchange Reduce Microplastics?
-
Jul 21, 2026, 00:46Yohei Hisada: Science, Collaboration, and New Beginnings at ISTH 2026
-
Jul 21, 2026, 00:41Ahmed Koriesh: Inside Our 2026 Stroke Simulation Lab
-
Jul 20, 2026, 21:17Connie Montgomery: Building Community Through the HFA Black Voices Summit
-
Jul 20, 2026, 21:15Leonie Bolt: Honored to Present on Coronary Artery Calcium Scoring in Hemophilia A at ISTH 2026
-
Jul 20, 2026, 21:12Mihir Jain: Can Gene Therapy Transform Hemophilia Care in India?
-
Jul 20, 2026, 21:10Mohammed W. Badri: Are We Doing Enough to Prevent Life-Threatening Bleeds in Children?
-
Jul 20, 2026, 19:56Asima Ahmad: Decoding Heavy Bleeding – What Your Symptoms Could Be Telling You